167 related articles for article (PubMed ID: 2161237)
1. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
[TBL] [Abstract][Full Text] [Related]
2. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
Sergiescu D; Gerfaux J; Joret AM; Chany C
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
[TBL] [Abstract][Full Text] [Related]
3. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
4. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.
Singh B; Stocking C; Walker R; Yang YD; Ostertag W; Arlinghaus RB
J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
Cizdziel PE; Nash MA; Blair DG; Murphy EC
J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
[TBL] [Abstract][Full Text] [Related]
6. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
[TBL] [Abstract][Full Text] [Related]
7. v-mos protein produced by in vitro translation has protein kinase activity.
Herzog NK; Nash M; Ramagli LS; Arlinghaus RB
J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564
[TBL] [Abstract][Full Text] [Related]
8. Analysis of metal-induced mutations altering the expression or structure of a retroviral gene in a mammalian cell line.
Biggart NW; Murphy EC
Mutat Res; 1988 Mar; 198(1):115-29. PubMed ID: 2832750
[TBL] [Abstract][Full Text] [Related]
9. Functions of the mos oncogene family and associated gene products.
Bold RJ; Hannink M; Donoghue DJ
Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
[TBL] [Abstract][Full Text] [Related]
10. The P55 protein affected by v-mos expression is vimentin.
Singh B; Goldman R; Hutton L; Herzog NK; Arlinghaus RB
J Virol; 1987 Nov; 61(11):3625-9. PubMed ID: 2822968
[TBL] [Abstract][Full Text] [Related]
11. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
O'Hara BM; Blair DG
Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
[TBL] [Abstract][Full Text] [Related]
12. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma.
Greenhalgh DA; Welty DJ; Player A; Yuspa SH
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):643-7. PubMed ID: 2153961
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of a monoclonal antibody to the v-mos oncogene protein.
Ishikawa K; Kurata N; Aoki H; Kato T; Marunouchi T
Hybridoma; 1991 Jun; 10(3):357-68. PubMed ID: 1833309
[TBL] [Abstract][Full Text] [Related]
14. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Fukasawa K; Vande Woude GF
Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
[TBL] [Abstract][Full Text] [Related]
15. Regulation of a collagen gene promoter by the product of viral mos oncogene.
Schmidt A; Setoyama C; de Crombrugghe B
Nature; 1985 Mar 21-27; 314(6008):286-9. PubMed ID: 2984572
[TBL] [Abstract][Full Text] [Related]
16. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern.
Fusco A; Portella G; Di Fiore PP; Berlingieri MT; Di Lauro R; Schneider AB; Vecchio G
J Virol; 1985 Oct; 56(1):284-92. PubMed ID: 2993656
[TBL] [Abstract][Full Text] [Related]
17. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
18. Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.
Gojobori T; Yokoyama S
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4198-201. PubMed ID: 2987967
[TBL] [Abstract][Full Text] [Related]
19. Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.
Norton JD; Cook F; Roberts PC; Clewley JP; Avery RJ
J Virol; 1984 May; 50(2):439-44. PubMed ID: 6323744
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor precursor is related to the translation product of the Moloney sarcoma virus oncogene mos.
Baldwin GS
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):1921-5. PubMed ID: 2984673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
